Jemperli eu smpc
WebJemperli contiene il principio attivo dostarlimab. Come si usa Jemperli? Il trattamento con Jemperli deve essere iniziato e seguito da un medico con esperienza nella cura del … WebJEMPERLI. is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) recurrent or advanced …
Jemperli eu smpc
Did you know?
Web18 giu 2024 · JEMPERLI 500 mg concentrate for solution for infusion Active Ingredient: dostarlimab Company: GlaxoSmithKline UK See contact details ATC code: L01XC40 About Medicine Prescription only medicine Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Live Chat WebRefer to the SmPC for a full list of adverse events. Overdose: Refer to SmPC. Legal Category: POM. Pack size: 1 vial of 500mg/10mL £5887.33 MA Number: EU/1/21/1538/001 MA Holder: GlaxoSmithKline (Ireland) Limited 12 Riverwalk Citywest Business Campus Dublin 24 Ireland Full SmPC available from GSK Limited or from www.medicines.org.uk.
WebDostarlimab (Jemperli™; GlaxoSmithKline) is a humanized monoclonal antibody programmed death-1 (PD-1) receptor antagonist being developed for the treatment of various cancers. Based on preliminary results from the GARNET trial dostarlimab has recently been approved in the EU and USA for the treatment of adult patients with … WebPrescribing Information (GB) ZEJULA (niraparib) is the only once-daily oral PARP inhibitor monotherapy approved for first-line platinum responders with advanced ovarian cancer regardless of biomarker status. 1-3 Extended PFS regardless of biomarker status vs placebo 1 VIEW EFFICACY Manageable safety and tolerability profile 4 VIEW SAFETY
WebThe MHRA products website allows you to find: The leaflets which are provided with medicines. The description of the medicinal product’s properties and how it can be used. Scientific reports about marketing authorisations for medicines. You can look for any word, phrase or Product Licence number (PL) using the search tool. WebAddress for visits and deliveries Refer to www.ema.europa.eu/how -to findus Send us a question Go to www.ema.europa.eu/contactTelephone+31 (0)88 781 6000. …
Web23 apr 2024 · European Commission Approves JEMPERLI (dostarlimab), the First Anti-PD-1 Therapy Approved for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer in …
WebSummary of product characteristics A document describing the properties and the officially approved conditions of use of a medicine. Summaries of product characteristics form the … free carpentry classes onlineWeb14 ott 2024 · Jemperli is a programmed death receptor-1 (PD-1)–blocking antibody indicated for: The treatment of adult patients with mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer, as determined by an FDA-approved test, that has progressed on or following prior treatment with a platinum-containing regimen. free car payment calculator with interestWebProfilo di Mauro Semprini (24) Taranto FC 1927 scheda, valore di mercato, statistiche, mercato, carriera e tanto altro free carpentry classes for womenWebJemperli must be initiated and supervised by specialist physicians experienced i n the treatment of cancer. Detailed recommendations for the use of this product will be … free carpentry classesWebJemperli 500 mg Konzentrat zur Herstellung einer Infusionslösung 1 Durchstechflasche, PZN 16902236 DOWNLOAD Fachinformation DOWNLOAD Gebrauchsinformation 🔒 Produktinformationen Sie möchten mehr über Jemperli erfahren? Kontaktieren Sie uns Bei Fragen zu unseren Produkten nehmen Sie gerne Kontakt auf. Besuch anfordern free carpathian booksWeb31 gen 2024 · Jemperli è un farmaco a base del principio attivo Dostarlimab, appartenente alla categoria degli Antineoplastici e nello specifico Inibitori di PD-1/PDL-1 (prot. morte cellulare prog. 1/ligand 1). E' commercializzato in Italia dall'azienda GlaxoSmithKline S.p.A.. free car park near melbourne cbdWeb26 feb 2024 · Jemperli is indicated as monotherapy for the treatment of adult patients with recurrent or advanced dMMR/MSI-H endometrial cancer that has progressed on or following prior treatment with a platinum-containing regimen. Jemperli must be initiated and supervised by specialist physicians experienced in the treatment of cancer. free carpenter resume templates